Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$43.88 - $56.16 $15.5 Million - $19.8 Million
-352,268 Reduced 16.86%
1,737,277 $96.5 Million
Q3 2022

Nov 14, 2022

BUY
$48.37 - $66.5 $9.22 Million - $12.7 Million
190,613 Added 10.04%
2,089,545 $106 Million
Q2 2022

Aug 15, 2022

SELL
$57.25 - $86.63 $2.82 Million - $4.26 Million
-49,215 Reduced 2.53%
1,898,932 $119 Million
Q1 2022

May 16, 2022

BUY
$71.02 - $86.99 $8.7 Million - $10.7 Million
122,470 Added 6.71%
1,948,147 $159 Million
Q4 2021

Feb 14, 2022

BUY
$76.72 - $92.68 $5.73 Million - $6.92 Million
74,658 Added 4.26%
1,825,677 $160 Million
Q3 2021

Nov 15, 2021

BUY
$76.02 - $88.62 $7.43 Million - $8.66 Million
97,723 Added 5.91%
1,751,019 $139 Million
Q2 2021

Aug 16, 2021

BUY
$73.44 - $87.01 $19.1 Million - $22.6 Million
260,172 Added 18.68%
1,653,296 $139 Million
Q1 2021

May 17, 2021

BUY
$62.9 - $82.41 $87.6 Million - $115 Million
1,393,124 New
1,393,124 $103 Million

Others Institutions Holding LIVN

About LivaNova PLC


  • Ticker LIVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,545,700
  • Market Cap $2.5B
  • Description
  • LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...
More about LIVN
Track This Portfolio

Track Eminence Capital, LP Portfolio

Follow Eminence Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eminence Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Eminence Capital, LP with notifications on news.